Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021

HomeBioIntelliSenseBioIntelliSense Forms Strategic Collaboration with the ACC

BioIntelliSense Forms Strategic Collaboration with the ACC

January 11, 2021

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the company has formed a strategic collaboration with the American College of Cardiology that combines innovative medical-grade wearable devices and data science to advance remote patient monitoring programs for cardiac care.

The American College of Cardiology will also offer the BioButton™ COVID-19 Screening Solution to provide an added layer of safety at the 70th Annual Scientific Session & Expo held May 15 – 17, 2021 in Atlanta.

The FDA-cleared BioSticker and medical-grade BioButton wearable devices allow for continuous vital sign monitoring of temperature, heart rate, and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. The strategic collaboration will combine ACC’s clinical expertise in heart health with BioIntelliSense’s effortless user experience and multi-parameter monitoring to make remote cardiac care scalable, reliable, and cost-effective.

ACC.21 will bring together cardiologists and cardiovascular specialists from around the world to share the newest discoveries in treatment and prevention. The ACC is committed to creating a healthy and safe environment for attendees, exhibitors and staff in line with all current directives and recommendations that will enable attendees to make informed and safe decisions about their attendance. In addition to all CDC recommended COVID-19 safety protocols, ACC.21 conference attendees will have the option to participate in the BioButton COVID-19 Screening Solution for continuous vital sign and symptom monitoring for COVID-like infection.  ACC.21 is the first major medical conference to use the BioButton solution.

James Mault, MD, CEO of BioIntelliSense, commented, “We are proud to form a strategic collaboration with the American College of Cardiology to advance virtual care and remote patient monitoring (RPM) programs that can transform cardiac care.  Together with the ACC, we can provide the cardiology community with medical-grade monitoring devices, clinically validated algorithms and RPM education that will have a profound impact on routine patient care globally.  The inclusion of BioButton COVID-19 Screening Program to the safety measures for the ACC Scientific Session will also serve to provide their cardiovascular professional membership an opportunity to experience the simplicity of virtual care and effortless remote monitoring.”

“The American College of Cardiology – and the cardiovascular community as a whole – has a long history of advancing innovative solutions to transform cardiovascular care and patient outcomes,” said ACC President Athena Poppas, MD, FACC. “We are excited by the opportunity to partner with BioIntelliSense and be on the cutting edge of an innovative technology with real-time health data and feedback.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy